Heinicke, U., Kupka, J., & Fulda, S. (2015). JNJ-26481585 primes rhabdomyosarcoma cells for chemotherapeutics by engaging the mitochondrial pathway of apoptosis. Oncotarget.
Chicago-стиль цитированияHeinicke, Ulrike, Johanna Kupka, and Simone Fulda. "JNJ-26481585 Primes Rhabdomyosarcoma Cells for Chemotherapeutics By Engaging the Mitochondrial Pathway of Apoptosis." Oncotarget 2015.
MLA-цитированиеHeinicke, Ulrike, Johanna Kupka, and Simone Fulda. "JNJ-26481585 Primes Rhabdomyosarcoma Cells for Chemotherapeutics By Engaging the Mitochondrial Pathway of Apoptosis." Oncotarget 2015.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.